Jovia Contraindications

Known hypersensitivity to escitalopram or citalopram or to any ingredient in the formulation; MAOIs: Cases of serious reactions have been reported in patients receiving SSRIs in combination with MAOI or the reversible MAOI (moclobemide) and in patient who have recently discontinued an SSRI and have been started on a MAOI. With the co-administration of an SSRI with MAOI, there have been reports of serious, sometimes fatal reactions including hyperthermia, rigidity, myoclonus, autonomic instability with possible fluctuations of vital signs, and mental status changes, including extreme agitation progressing to delirium and coma. Some cases presented with features resembling serotonin syndrome.
Therefore, escitalopram should not be used in combination with a MAOI or within 14 days of discontinuing treatment with a MAOI, (including linezolid, an antibiotic which is a reversible non-selective MAOI, and methylene blue, which is a MAOI). Similarly, at least 14 days should be elapse after discontinuing escitalopram treatment before starting a MAOI.
In patients with known QT interval prolongation or congenital long QT syndrome; Concomitant use with drugs that are known to prolong the QT interval (e.g., pimozide).